MoneyWorks4Me

Cipla reports marginal rise in Q3 consolidated net profit

27 Jan 2022 Evaluate

Cipla has reported results for third quarter ended December 31, 2021.

The company has reported a rise of 4.56% in its net profit at Rs 730.83 crore for the quarter under review as compared to Rs 698.93 crore for the same quarter in the previous year. Total income of the company increased by 5.23% at Rs 4,027.79 crore for Q3FY22 as compared Rs 3,827.67 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported a marginal rise of 0.70% in its net profit at Rs 756.88 crore for the quarter under review as compared to Rs 751.61 crore for the same quarter in the previous year. Total income of the company increased by 5.98% at Rs 5,570.15 crore for Q3FY22 as compared Rs 5,255.63 crore for the corresponding quarter previous year.

Peers
Company Name CMP
Sun Pharma. Inds. 1840.00
Dr. Reddys Labs. 1222.50
Cipla 1388.90
Lupin 2061.85
Zydus Lifesciences 1212.00
View more..